As of 2024-07-27, the Relative Valuation of Vertex Pharmaceuticals Inc (VRTX) is 556.58 USD. This relative valuation is based on P/E multiples. With the latest stock price at 495.26 USD, the upside of Vertex Pharmaceuticals Inc based on Relative Valuation is 12.4%.
The range of the Relative Valuation is 512.76 - 683.17 USD.
| Range | Selected | |
| Trailing P/E multiples | 32.9x - 43.9x | 36.6x |
| Forward P/E multiples | 31.5x - 37.1x | 33.0x |
| Fair Price | 512.76 - 683.17 | 556.58 |
| Upside | 3.5% - 37.9% | 12.4% |
| Date | P/E |
| 2024-07-26 | 31.80 |
| 2024-07-25 | 31.60 |
| 2024-07-24 | 31.51 |
| 2024-07-23 | 31.48 |
| 2024-07-22 | 31.84 |
| 2024-07-19 | 31.56 |
| 2024-07-18 | 31.34 |
| 2024-07-17 | 31.35 |
| 2024-07-16 | 31.39 |
| 2024-07-15 | 31.51 |
| 2024-07-12 | 31.38 |
| 2024-07-11 | 31.60 |
| 2024-07-10 | 31.56 |
| 2024-07-09 | 31.20 |
| 2024-07-08 | 30.94 |
| 2024-07-05 | 30.47 |
| 2024-07-03 | 30.19 |
| 2024-07-02 | 30.42 |
| 2024-07-01 | 30.25 |
| 2024-06-28 | 30.09 |
| 2024-06-27 | 30.34 |
| 2024-06-26 | 30.43 |
| 2024-06-25 | 30.42 |
| 2024-06-24 | 30.49 |
| 2024-06-21 | 30.09 |
| 2024-06-20 | 30.26 |
| 2024-06-18 | 30.00 |
| 2024-06-17 | 30.41 |
| 2024-06-14 | 30.86 |
| 2024-06-13 | 30.75 |
| 2024-06-12 | 30.55 |
| 2024-06-11 | 30.91 |
| 2024-06-10 | 31.03 |
| 2024-06-07 | 31.01 |
| 2024-06-06 | 31.17 |
| 2024-06-05 | 31.01 |
| 2024-06-04 | 30.49 |
| 2024-06-03 | 30.19 |
| 2024-05-31 | 29.23 |
| 2024-05-30 | 28.44 |
| 2024-05-29 | 28.32 |
| 2024-05-28 | 28.69 |
| 2024-05-24 | 29.34 |
| 2024-05-23 | 28.94 |
| 2024-05-22 | 28.73 |
| 2024-05-21 | 28.38 |
| 2024-05-20 | 28.63 |
| 2024-05-17 | 28.58 |
| 2024-05-16 | 28.29 |
| 2024-05-15 | 28.09 |